NCT06457594View on ClinicalTrials.gov

Prospective PROM and PREM Analysis Demonstrating Specification Advantage and Language Barriers

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

June 8, 2024

Conditions
Head and Neck Cancer
Interventions
OTHER

Questionnaire

EORTC QLQ-INFO25 EORTC QLQ - H\&N43 and EORTC QLQ-C30

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT06457594 - Prospective PROM and PREM Analysis Demonstrating Specification Advantage and Language Barriers | Biotech Hunter | Biotech Hunter